相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Loss of ADAM9 expression impairs β1 integrin endocytosis, focal adhesion formation and cancer cell migration
Kasper J. Mygind et al.
JOURNAL OF CELL SCIENCE (2018)
A Disintegrin and Metalloproteinase Domain-9: A Novel Proteinase Culprit with Multifarious Contributions to Chronic Obstructive Pulmonary Disease
Xiaoyun Wang et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
ADAM9 is over-expressed in human ovarian clear cell carcinomas and suppresses cisplatin-induced cell death
Mari Ueno et al.
CANCER SCIENCE (2018)
Sorting nexin 9 (SNX9) regulates levels of the transmembrane ADAM9 at the cell surface
Kasper J. Mygind et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Proteomic Characterization of Prostate Cancer to Distinguish Nonmetastasizing and Metastasizing Primary Tumors and Lymph Node Metastases
Ann-Kathrin Mueller et al.
NEOPLASIA (2018)
KRAS/NF-κB/YY1/miR-489 Signaling Axis Controls Pancreatic Cancer Metastasis
Peng Yuan et al.
CANCER RESEARCH (2017)
Deletion of ADAM-9 in HGF/CDK4 mice impairs melanoma development and metastasis
N. Giebeler et al.
ONCOGENE (2017)
Challenges in pancreatic adenocarcinoma surgery - National survey and current practice guidelines
Sameer A. Dhayat et al.
PLOS ONE (2017)
A pathology atlas of the human cancer transcriptome
Mathias Uhlen et al.
SCIENCE (2017)
ADAM9 expression promotes an aggressive lung adenocarcinoma phenotype
Celine Mongaret Kossmann et al.
TUMOR BIOLOGY (2017)
ADAM9 promotes lung cancer progression through vascular remodeling by VEGFA, ANGPT2, and PLAT
Chen-Yuan Lin et al.
SCIENTIFIC REPORTS (2017)
Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
ADAM9 is present at endothelial cell - cell junctions and regulates monocyte - endothelial transmigration
William R. English et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
miRNA-520f Reverses Epithelial-to-Mesenchymal Transition by Targeting ADAM9 and TGFBR2
Jasmijn G. M. van Kampen et al.
CANCER RESEARCH (2017)
KrasG12D induces EGFR-MYC cross signaling in murine primary pancreatic ductal epithelial cells
S. Diersch et al.
ONCOGENE (2016)
ADAM9 silencing inhibits breast tumor cells transmigration through blood and lymphatic endothelial cells
Kelli Cristina Micocci et al.
BIOCHIMIE (2016)
The ADAMs family of proteases as targets for the treatment of cancer
Maeve Mullooly et al.
CANCER BIOLOGY & THERAPY (2016)
ADAM10-mediated release of heregulin confers resistance to trastuzumab by activating HER3
Eva A. Ebbing et al.
ONCOTARGET (2016)
A Disintegrin and Metalloprotease (ADAM): Historical Overview of Their Functions
Nives Giebeler et al.
TOXINS (2016)
Platelet integrin α6β1 controls lung metastasis through direct binding to cancer cell-derived ADAM9
Elmina Mammadova-Bach et al.
JCI INSIGHT (2016)
ADAM9 Expression Is Associate with Glioma Tumor Grade and Histological Type, and Acts as a Prognostic Factor in Lower-Grade Gliomas
Xing Fan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms
Alexander Nystroem et al.
EMBO MOLECULAR MEDICINE (2015)
Detailed analysis of epithelial-mesenchymal transition and tumor budding identifies predictors of long-term survival in pancreatic ductal adenocarcinoma
Ilona Kohler et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2015)
ADAM-9 is a novel mediator of tenascin-C-stimulated invasiveness of brain tumor-initiating cells
Susobhan Sarkar et al.
NEURO-ONCOLOGY (2015)
Perspectives in the treatment of pancreatic adenocarcinoma
Angel Cid-Arregui et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
The Effect of Disintegrin-Metalloproteinase ADAM9 in Gastric Cancer Progression
Jeong Min Kim et al.
MOLECULAR CANCER THERAPEUTICS (2014)
EGF Receptor Signaling Is Essential for K-Ras Oncogene-Driven Pancreatic Ductal Adenocarcinoma
Carolina Navas et al.
CANCER CELL (2012)
EGF Receptor Is Required for KRAS-Induced Pancreatic Tumorigenesis
Christine M. Ardito et al.
CANCER CELL (2012)
MT1-MMP Inactivates ADAM9 to Regulate FGFR2 Signaling and Calvarial Osteogenesis
Kui Ming Chan et al.
DEVELOPMENTAL CELL (2012)
Pro-inflammatory interleukin-18 increases Alzheimer's disease-associated amyloid-β production in human neuron-like cells
Elina M. Sutinen et al.
JOURNAL OF NEUROINFLAMMATION (2012)
MiR-126 Acts as a Tumor Suppressor in Pancreatic Cancer Cells via the Regulation of ADAM9
Shin Hamada et al.
MOLECULAR CANCER RESEARCH (2012)
Hypoxia Changes the Expression of the Epidermal Growth Factor (EGF) System in Human Hearts and Cultured Cardiomyocytes
Mathias Munk et al.
PLOS ONE (2012)
Proteolytic Activity Matrix Analysis (PrAMA) for simultaneous determination of multiple protease activities
Miles A. Miller et al.
INTEGRATIVE BIOLOGY (2011)
The Disintegrin-like and Cysteine-rich domains of ADAM-9 Mediate Interactions between Melanoma Cells and Fibroblasts
Paola Zigrino et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Overcoming anoikis - pathways to anchorage-independent growth in cancer
Marta C. Guadamillas et al.
JOURNAL OF CELL SCIENCE (2011)
Inhibition of ADAM9 Expression Induces Epithelial Phenotypic Alterations and Sensitizes Human Prostate Cancer Cells to Radiation and Chemotherapy
Sajni Josson et al.
PROSTATE (2011)
Chemotherapy-Induced Activation of ADAM-17: A Novel Mechanism of Drug Resistance in Colorectal Cancer
Joan N. Kyula et al.
CLINICAL CANCER RESEARCH (2010)
Sorafenib Inhibits the Shedding of Major Histocompatibility Complex Class I-Related Chain A on Hepatocellular Carcinoma Cells by Down-Regulating a Disintegrin and Metalloproteinase 9
Keisuke Kohga et al.
HEPATOLOGY (2010)
Loss of the Metalloprotease ADAM9 Leads to Cone-Rod Dystrophy in Humans and Retinal Degeneration in Mice
David A. Parry et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2009)
Inhibition of platelets and tumor cell adhesion by the disintegrin domain of human ADAM9 to collagen I under dynamic flow conditions
Marcia R. Cominetti et al.
BIOCHIMIE (2009)
ADAM9 as a Potential Target Molecule in Cancer
Lucie Peduto
CURRENT PHARMACEUTICAL DESIGN (2009)
ADAM9 Is Involved in Pathological Retinal Neovascularization
Victor Guaiquil et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
APP binds DR6 to trigger axon pruning and neuron death via distinct caspases
Anatoly Nikolaev et al.
NATURE (2009)
Anchorage-independent cell growth signature identifies tumors with metastatic potential
S. Mori et al.
ONCOGENE (2009)
Establishment of clonal colony-forming assay for propagation of pancreatic cancer cells with stem cell properties
Shanmiao Gou et al.
PANCREAS (2007)
HB-EGF promotes angiogenesis in endothelial cells via PI3-kinase and MAPK signaling pathways
Veela B. Mehta et al.
GROWTH FACTORS (2007)
Meta-analysis of microarray data on pancreatic cancer defines a set of commonly dysregulated genes
R Grützmann et al.
ONCOGENE (2005)
Secreted form of ADAM9 promotes carcinoma invasion through tumor-stromal interactions
A Mazzocca et al.
CANCER RESEARCH (2005)
Gene expression analysis of pancreatic cell lines reveals genes overexpressed in pancreatic cancer
I Alldinger et al.
PANCREATOLOGY (2005)
Adams: Key components in EGFR signalling and development
CP Blobel
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma
R Grützmann et al.
BRITISH JOURNAL OF CANCER (2004)
Expression of ADAM-9 mRNA and protein in human breast cancer
C O'Shea et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Increased expression of disintegrin-metalloproteinases ADAM-15 and ADAM-9 following upregulation of integrins α5β1 and αvβ3 in atherosclerosis
N Al-Fakhri et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2003)
The metalloprotease disintegrin ADAM8 - Processing by autocatalysis is required for proteolytic activity and cell adhesion
U Schlomann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The enzymatic activity of ADAM8 and ADAM9 is not regulated by TIMPs
A Amour et al.
FEBS LETTERS (2002)
A secreted form of human ADAM9 has an α-secretase activity for APP
N Hotoda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Mice lacking the metalloprotease-disintegrin MDC9 (ADAM9) have no evident major abnormalities during development or adult life
G Weskamp et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
分享论文
